dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorPontifícia Universidade Católica de São Paulo (PUC-Sorocaba)
dc.date.accessioned2018-12-11T17:20:58Z
dc.date.available2018-12-11T17:20:58Z
dc.date.created2018-12-11T17:20:58Z
dc.date.issued2018-05-01
dc.identifierAnais Brasileiros de Dermatologia, v. 93, n. 3, p. 451-453, 2018.
dc.identifier1806-4841
dc.identifier0365-0596
dc.identifierhttp://hdl.handle.net/11449/176483
dc.identifier10.1590/abd1806-4841.20187419
dc.identifierS0365-05962018000300451
dc.identifier2-s2.0-85048821475
dc.identifierS0365-05962018000300451.pdf
dc.description.abstractHypereosinophilic syndrome is defined as persistent eosinophilia (>1500/µL for more than six months) associated with organ involvement, excluding secondary causes. It is a rare, potentially lethal disease that should be considered in cutaneous conditions associated with hypereosinophilia. We report a case of erythroderma as a manifestation of hypereosinophilic syndrome. A 36-year-old male with no comorbidities presented progressive erythroderma, pruritus, peripheral neuropathy, and eosinophilia in the previous seven months. No mutations were found in FIP1L1/PDGFRA. Patient experienced rapid remission in response to oral prednisone and hydroxyurea. Cutaneous manifestations may be the only evidence of hypereosinophilic syndrome. Genotyping excludes myeloproliferative disease, thereby orienting treatment and prognosis.
dc.languageeng
dc.relationAnais Brasileiros de Dermatologia
dc.relation0,520
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectDermatitis
dc.subjectEosinophilia
dc.subjectExfoliative
dc.subjectPolyneuropathies
dc.titleCase for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución